Goodbye or arrivederci?

1 October 2015 0

Our new vocabulary – gene, genome, molecular, targeted, personalised – no longer inspires the confidence it once did, and as the cancer community prepares to gather at the 18th ECCO – 40th ESMO European Cancer [more]

Our new vocabulary – gene, genome, molecular, targeted, personalised – no longer inspires the confidence it once did, and as the cancer community prepares to gather at the 18th ECCO - 40th ESMO European Cancer Congress in Vienna..... [ more ]

Denis Lacombe quietly orchestrating the clinical research revolution

1 October 2015 0

The scientific complexity and economic cost of developing new cancer therapies demand a level of collaboration and sharing that takes both industry and academia well beyond their comfort zones. EORTC head Denis Lacombe believes he [more]

The scientific complexity and economic cost of developing new cancer therapies demand a level of collaboration and sharing that takes both industry and academia well beyond their comfort zones. EORTC head Denis Lacombe believes he... [ more ]

What can we learn from liquid biopsies?

1 October 2015 0

Early detection, disease prognosis, a guide to treatment, a key to unlock the secrets of how cancers evolve. Researchers have high hopes for what they can learn from the biological detritus shed by primary tumours [more]

Early detection, disease prognosis, a guide to treatment, a key to unlock the secrets of how cancers evolve. Researchers have high hopes for what they can learn from the biological detritus shed by primary tumours and metastases.... [ more ]

Asking the dumb questions

1 October 2015 0

It took ten years of immersion in the world of cancer research to produce the book that won Clifton Leaf a Best Cancer Reporter Lifetime Achievement award. But it started from a simple question: how [more]

It took ten years of immersion in the world of cancer research to produce the book that won Clifton Leaf a Best Cancer Reporter Lifetime Achievement award. But it started from a simple question...... [ more ]

Championing healthcare in an age of austerity: an interview with the European Health Commissioner

1 October 2015 0

Vytenis Andriukaitis talks to Cancer World’s Anna Wagstaff about what Europe needs to do to safeguard and extend access to high-quality cancer care in challenging times. How can European countries provide a rapidly rising number [more]

Vytenis Andriukaitis talks to Cancer World’s Anna Wagstaff about what Europe needs to do to safeguard and extend access to high-quality cancer care in challenging times.... [ more ]

Are progression-free and disease-free survival the new gold standard for cancer trials?

1 October 2015 0

Showing that a new drug can keep advanced cancers from progressing, or stop early cancers from returning, is quicker, cheaper and easier than showing that it helps patients live longer. But how can we judge [more]

Showing that a new drug can keep advanced cancers from progressing, or stop early cancers from returning, is quicker, cheaper and easier than showing that it helps patients live longer. ... [ more ]

Rerouted, not derailed: resuming a young life after cancer

1 October 2015 0

Paediatric oncologists are highly focused on how to minimise and manage the life-long damage their treatments inflict on young patients’ health. But for young survivors, the most immediate challenge is how to get an interrupted [more]

Paediatric oncologists are highly focused on how to minimise and manage the life-long damage their treatments inflict on young patients’ health. But for young survivors, the most immediate challenge is how to get an interrupted...... [ more ]

The moment medical students discover a profound appreciation for humanity

1 October 2015 0

A great short piece by medical student Armaan Rowther flagging up the role of anatomy labs in shaping medics’ attitudes towards their future patients. “Is the language of medicine that is learned in anatomy lab [more]

A great short piece by medical student Armaan Rowther flagging up the role of anatomy labs in shaping medics’ attitudes towards their future patients. "Is the language of medicine that is learned in anatomy ... [ more ]

Newsround

1 October 2015 0

Elderly breast cancer patients do not benefit from radiotherapy => European Journal of Cancer Most elderly patients with pT1 breast cancer treated by quadrantectomy do not benefit from radiotherapy, the results of 15 years of [more]

Elderly breast cancer patients do not benefit from radiotherapy
... [ more ]
UA-77507851-1